Report ID: 10151785 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
"Factors driving market growth include the benefits of particle therapy and the increase in global cancer prevalence. It has been found that the number of people with various types of cancer is an important determinant of this market. Cancer is one of the main life-threatening diseases of our time.
According to the World Health Organization, cancer is the second leading cause of death in the world, causing approximately 9.6 million deaths in 2018. Globally, approximately one in six deaths is caused by cancer. Approximately 70% of cancer deaths occur in low- and middle-income countries. As particle therapy is used to treat cancer, the increasing popularity of particle therapy is expected to be the main driving force for the growth of this market.
Report scope:
According to the report scope, particle therapy is the frontier field of external beam radiotherapy. It uses neutron beams, proton beams or other heavier positive ion beams to treat cancer.
Main market trends:
It is expected that the application of particle therapy in lung cancer will maintain a considerable share in the prognosis period. When traditional radiotherapy is used to treat lung cancer, it is difficult to provide effective doses without harming healthy tissues. Using proton therapy to treat lung cancer, doctors can deliver efficient and precise doses of protons to the exact location of the lung cancer.
Proton therapy for lung cancer has been proven to be a reasonable treatment for patients whose cancer is confined to the chest; in addition, according to a 2018 report by the World Health Organization, lung cancer is the world's leading form of cancer and cause of death. The report shows that there are 2.09 million cases of lung cancer and 1.76 million cases of lung cancer, ranking first among all cancers. This factor is expected to increase the demand for more effective therapies such as particle therapy, thereby driving market growth.
North America dominates the market and is expected to do so during the forecast period:
North America dominates the global market studied in 2020. Almost half of cancer patients in this region, especially in the United States, receive cancer treatment. The United States has the largest radiotherapy market. The market is driven by factors such as the increase in cancer incidence, the replacement of old therapies with new therapies, and the availability of reimbursement for radiotherapy.
Some states in the United States have passed laws requiring personnel who perform radiological procedures to obtain permits. Changes in the legislature and the availability of reimbursement policies have prompted providers to control costs while improving patient care and treatment outcomes. With substantial investment in the research and development of innovative technologies for particle therapy, the market is expected to grow during the forecast period.
North America dominates the market and is expected to do so during the forecast period: North America dominated the global market studied in 2020. Almost half of cancer patients in this region, especially in the United States, receive cancer treatment.
The United States has the largest radiotherapy market. The market is driven by factors such as the increase in cancer incidence, the replacement of old therapies with new therapies, and the availability of reimbursement for radiotherapy. Some states in the United States have passed laws requiring personnel who perform radiological procedures to obtain permits. Changes in the legislature and the availability of reimbursement policies have prompted providers to control costs while improving patient care and treatment outcomes. With substantial investment in the research and development of innovative technologies for particle therapy, the market is expected to grow during the forecast period.
Competitive landscape:
The global particle therapy market is moderately competitive and consists of several major players. Danfysik A/S, Hitachi, Ltd., Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Protom International, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Companies such as Varian Medical Systems, Inc. have considerable market shares in the particle therapy market."
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10151785 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
